Abstract:Multiresponsive nanoprobes are highly desirable for low background and highly sensitive imaging in biomedical applications. Herein, we design a glutathione (GSH)/pH dual-responsive nanoprobe capable of both fluorescence imaging in cells and 19F magnetic resonance imaging (19F MRI) in deep tissue, by encapsulating manganese oleate (Mn(OA)2) on the surface of fluorinated fluorescent quantum dots (F-ZnS:Mn2+). In this approach, Mn(OA)2 serves as an efficient quencher of both fluorescence and 19F MRI signal. Both the fluorescence and 19F MRI signal can be turned on by introducing glutathione (GSH) that breaks up the Mn–O bonds within Mn(OA)2 under weak acidity conditions (e.g., pH 6.0). The imaging results in cells and mice suggest that this novel strategy can offer a promising nanoprobe for turn-on fluorescence/19F MRI dual-modal tumor imaging.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c01786?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c01786</a>.XRD pattern of ZnS:Mn2+ QDs (Figure S1); HRTEM images of ZnS:Mn2+-F-Mn(OA)2@PSIOAm before and after reaction with GSH (Figure S2); FT-IR spectra of ZnS:Mn2+ QDs (the ligand is oleic acid), Mn(OA)2, PFCE, PSIOAm, and ZnS:Mn2+-F-Mn(OA)2@PSIOAm (Figure S3); UV–Vis absorption spectrum of Mn(OA)2 and fluorescence spectra of ZnS:Mn2+@PSIOAm and ZnS:Mn2+-Mn(OA)2@PSIOAm (Figure S4); UV–Vis absorption of ZnS:Mn2+OAm and ZnS:Mn2+-F-Mn(OA)2@PSIOAm (Figure S5); 19F NMR spectra of ZnS:Mn2+-F-Mn(OA)2@PSIOAm aqueous solution before and after reaction with GSH (10 mM) at pH 6.0 (Figure S6); UV–Vis absorption spectra and ICP-OES measurements of the Mn content in the supernatants of ZnS-Mn(OA)2@PSIOAm colloidal solution under different conditions (Figure S7); selectivity of ZnS:Mn2+-F-Mn(OA)2@PSIOAm toward GSH (Figure S8); cytotoxicity tests of ZnS:Mn2+-F-Mn(OA)2@PSIOAm colloids after incubation with HUVECs and 4T1 cell lines (Figure S9); flow cytometry analysis of MREpiC and 4T1 cells incubated with ZnS:Mn2+-F-NLR-Mn(OA)2@PSIOAm (Figure S10); stability evaluation of ZnS:Mn2+-F-Mn(OA)2@PSIOAm colloid solution (Figure S11); T1-weighted and T2-weighted 1H MR imaging of ZnS:Mn2+-F-Mn(OA)2@PSIOAm under different conditions (Figure S12); and fluorescence images of 4T1 cells cultured with ZnS:Mn2+-F-Mn(OA)2@PSIOAm nanoprobes for different time (Figure S13) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c01786/suppl_file/ac0c01786_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Fe<sub>3</sub>O<sub>4</sub>–ZIF-8 assemblies as pH and glutathione responsive <i>T</i><sub>2</sub>–<i>T</i><sub>1</sub> switching magnetic resonance imaging contrast agent for sensitive tumor imaging <i>in vivo</i>

Fe3o4-Zif-8 Assemblies As Ph And Glutathione Responsive T-2-T-1 Switching Magnetic Resonance Imaging Contrast Agent For Sensitive Tumor Imaging In Vivo

Ph and Glutathione Synergistically Triggered Release and Self-Assembly of Au Nanospheres for Tumor Theranostics.

Manganese Oxide/metal-Organic Frameworks-Based Nanocomposites for Tumr Micro-environment Sensitive 1H/19F Dual-mode Magnetic Resonance Imaging in Vivo

Dynamically Reversible Iron Oxide Nanoparticle Assemblies For Targeted Amplification Of T1-Weighted Magnetic Resonance Imaging Of Tumors

Tumor micro-environment sensitive 19F-magnetic resonance imaging in vivo

Bimetallic Zeolitic Imidazolate Framework As an Intrinsic Two-Photon Fluorescence and Ph-Responsive MR Imaging Agent

Extremely Small Iron Oxide Nanoparticles with Ph-Dependent Solubility Transition As T1/T2 Switchable Contrast Agents for MRI

Redox-Sensitive Clustered Ultrasmall Iron Oxide Nanoparticles for Switchable T2/T1-Weighted Magnetic Resonance Imaging Applications

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

Tumor Acid Microenvironment-Triggered Self-Assembly of ESIONPs for T1/T2 Switchable Magnetic Resonance Imaging

Cubic Zinc-Doped Iron Oxide Nanoparticles with Poly(Ethylene Glycol) or Sodium Citrate Surface Coatings for Tumor Imaging

D-Alpha-Tocopheryl Poly(ethylene Glycol 1000) Succinate-Coated Manganese-Zinc Ferrite Nanomaterials for a Dual-Mode Magnetic Resonance Imaging Contrast Agent and Hyperthermia Treatments

Mesoporous MnSiO3@Fe3O4@C Nanoparticle As Ph-Responsive T1-T2* Dual-Modal Magnetic Resonance Imaging Contrast Agent for Tumor Diagnosis

Hypoxia-Responsive T<sub>2</sub>-to-T<sub>1</sub> Dynamically Switchable Extremely Small Iron Oxide Nanoparticles for Sensitive Tumor Imaging In Vivo

Naturally Biocompatible Melanin Based Iron-Complex Nanoparticles for Ph-Responsive Magnetic Resonance Imaging.

Hypoxia-Responsive T 2 -to-T 1 Dynamically Switchable Extremely Small Iron Oxide Nanoparticles for Sensitive Tumor Imaging In Vivo

Redox-triggered Aggregation of ESIONPs with Switchable T1 to T2 Contrast Effect for T2-weighted Magnetic Resonance Imaging.

Multiresponsive Nanoprobes for Turn-On Fluorescence/ 19 F MRI Dual-Modal Imaging

Hypoxia-Responsive Aggregation of Iron Oxide Nanoparticles for T1-to-T2 Switchable Magnetic Resonance Imaging of Tumors

In vivo aggregation-induced transition between T 1 and T 2 relaxations of magnetic ultra-small iron oxide nanoparticles in tumor microenvironment.